|
Receptors
Citations 1-10 of 17 total displayed.
|
Most recent content
(1 Oct 2008):
|
- NEWS
Denosumab and the Treatment of Rheumatoid Arthritis: In an Occupied Field, Where Will a RANKL Inhibitor Fit In?
- Neil A. Andrews
IBMS BoneKEy 2008; 5: 351-356.
[Full text]
[PDF]
|
Past content
(since Mar 2001):
|
- Commentaries
A New PPAR- Function in Bone
- Ichiro Takada and Shigeaki Kato
IBMS BoneKEy 2008; 5: 258-261.
[Full text]
[PDF]
- Perspectives
Anabolic Therapy for Osteoporosis: Calcilytics
- Edward F. Nemeth
IBMS BoneKEy 2008; 5: 196-208.
[Abstract]
[Full text]
[PDF]
- Commentaries
Crystal Structure of the Extracellular Domain of the PTH/PTHrP Receptor
- Thomas J. Gardella
IBMS BoneKEy 2008; 5: 171-175.
[Full text]
[PDF]
- Commentaries
Estrogen and the Death of Osteoclasts: A Fascinating Story
- Sundeep Khosla
BoneKEy-Osteovision 2007; 4: 267-272.
[Full text]
[PDF]
- Commentaries
Is Estrogen Receptor  an Osteoblastic Mechanosensor?
- Shigeaki Kato and Ryoji Fujiki
BoneKEy-Osteovision 2007; 4: 273-277.
[Full text]
[PDF]
- Perspectives
Wnt Signaling in Bone
- Peter V. Bodine
BoneKEy-Osteovision 2007; 4: 108-123.
[Abstract]
[Full text]
[PDF]
- NEWS
Bidirectional Signaling in Bone: A new study pinpoints a role for ephrin/Eph signaling in crosstalk between osteoblasts and osteoclasts
- Neil A. Andrews
BoneKEy-Osteovision 2006; 3: 6-9.
[Full text]
[PDF]
- NEWS
RANKL: A Soil Factor for Cancer Metastasis to Bone?: Evidence builds for a key role for RANKL in the spread of cancer to bone, but further experiments are necessary to cinch the case
- Neil A. Andrews
BoneKEy-Osteovision 2006; 3: 6-9.
[Full text]
[PDF]
- Commentaries
Current, New and Emerging Anti-Resorptive Drugs; Antibody Blockade Of RANKL Action
- T. John Martin
BoneKEy-Osteovision 2006; 3: 42-46.
[Full text]
[PDF]
|
|
